Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Annals of Surgical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-015-4627-8PMID 26014158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy

  2017cited by this paper
• Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers.

  2015cited by this paper
• Extent of Colorectal Peritoneal Carcinomatosis: Attempt to Define a Threshold Above Which HIPEC Does Not Offer Survival Benefit: A Comparative Study

  2015cited by this paper
• Summary of current therapeutic options for peritoneal metastases from colorectal cancer

  2013influential reference
• Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy?

  2013cited by this paper
• Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy

  2013cited by this paper
• Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?

  2012cited by this paper
• Variation in the peritoneal cancer index scores between surgeons and according to when they are determined (before or after cytoreductive surgery).

  2012influential reference
• Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.

  2012cited by this paper
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement

  2011cited by this paper
• Results of Two Bi-Institutional Prospective Studies Using Intraperitoneal Oxaliplatin With or Without Irinotecan During HIPEC After Cytoreductive Surgery for Colorectal Carcinomatosis

  2011influential reference
• Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study.

  2010influential reference
• Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

  2009cited by this paper
• The intraoperative staging systems in the management of peritoneal surface malignancy

  2008cited by this paper
• Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Isolated Colorectal Peritoneal Carcinomatosis: Experimental Therapy or Standard of Care?

  2008cited by this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology.

  2007cited by this paper
• Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.

  2006cited by this paper
• Treatment of Peritoneal Carcinomatosis From Colorectal Cancer: Impact of Complete Cytoreductive Surgery and Difficulties in Conducting Randomized Trials

  2004cited by this paper
• Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin

  2004cited by this paper
• Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

  2004influential reference
• Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance.

  2004cited by this paper
• Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection.

  2000cited by this paper
• Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis.

  1998influential reference
• Peritonectomy procedures.

  1996influential reference
• Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis.

  1995cited by this paper
• Peritonectomy procedures.

  1995cited by this paper

• Exploring the frontier: promising survival in selected patients after CRS and HIPEC for peritoneal metastases from hepatocellular carcinoma-a systematic review.

  2026cites this paper
• CT‐based radiomics–clinical machine‐learning model to predict completeness of cytoreduction in colorectal peritoneal metastases

  2026cites this paper
• Regional differences in surgical strategies for peritoneal metastases based on various perspectives on oligometastases.

  2026cites this paper
• Pressurized intraperitoneal aerosol chemotherapy in advanced colorectal cancer with peritoneal metastases: a meta-analysis of feasibility, efficacy, and safety

  2025cites this paper
• Can Peritoneal Cancer Index be Determined in 18F-FDG PET/CT Before Surgery in Ovarian Peritoneal Carcinomatosis?

  2025cites this paper
• MRI-guided stereotactic radiotherapy for oligometastatic peritoneal carcinomatosis: toward integrative oncologic approaches

  2025cites this paper
• Prognostic value of neutrophil-to-lymphocyte ratio and CA 19–9 in overall survival of patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

  2025cites this paper
• Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) and Liver-Directed Therapy for Synchronous Peritoneal and Liver Metastatic Colorectal Cancer: A Systematic Review with Meta-analysis

  2025influential citation
• Clinical significance of preoperative Glasgow prognostic score in patients with colorectal cancer and synchronous peritoneal metastases

  2025cites this paper
• Challenges of Nontherapeutic Laparotomy in Patients with Peritoneal Surface Malignancies Selected for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2025cites this paper
• Comparative Effectiveness of Artificial Intelligence Versus Conventional Methods for Detecting Peritoneal Metastasis in Colorectal Cancer: A Systematic Review

  2025cites this paper
• Pre-operative predictors of completeness of cytoreduction for colorectal peritoneal metastases: a systematic review of radiological, clinicopathological and biomarker-based predictors.

  2025cites this paper
• Pathological PCI as a prognostic marker of survival after neoadjuvant chemotherapy in patients undergoing interval cytoreduction with or without HIPEC in FIGO stage IIIC high grade serous ovarian cancer

  2024cites this paper
• Peritoneal Cancer Index Correlates with Radiographic Assessment of Colorectal Carcinomatosis

  2024cites this paper
• INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases

  2024cites this paper
• Treatment and Management of Peritoneal Spread from Colorectal Cancer Peritoneal Metastasis.

  2024cites this paper
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is NOT a Last Resort: Rationale for Early Surgical Referral.

  2024cites this paper
• Review of Options to Traditional HIPEC for Prevention and Treatment of Peritoneal Metastases

  2024cites this paper
• Imaging in malignant peritoneal neoplasms

  2024cites this paper
• Evaluation of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for the diagnosis of recurrent colorectal cancers

  2024cites this paper
• Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy: Results of Phase I of the PRECINCT Study in 707 Patients

  2024cites this paper
• Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer

  2024cites this paper
• The CEA/PCI ratio is a superior prognosticator than mCOREP for colorectal cancer patients with peritoneal carcinomatosis

  2024cites this paper
• Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resection

  2024cites this paper
• Peritoneal Carcinomatosis of Malignant Gynecological Origin: A Systematic Review of Imaging Assessment

  2024cites this paper
• Value of three-dimensional reconstruction for non-invasive estimation of PCI in patients with peritoneal carcinomatosis of colorectal origin: A proof of concept

  2024cites this paper
• Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence

  2024cites this paper
• The peritoneal cancer index as a predictor of complete cytoreduction at primary and interval cytoreductive surgery in advanced ovarian cancer

  2023cites this paper
• The Vermiform Appendix and Its Pathologies

  2023cites this paper
• Prognostic indicators for colorectal peritoneal metastases are different for patients with complete versus incomplete cytoreductive surgery

  2023cites this paper
• Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement

  2023cites this paper
• Peritoneal carcinomatosis index and overall survival in patients taken to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

  2023cites this paper
• Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncologic Clinicians

  2023cites this paper
• Robotic Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy

  2023cites this paper
• Value of three-dimensional reconstruction for non-invasive estimation of PCI in patients with peritoneal carcinomatosis of colorectal origin: A proof of concept.

  2023cites this paper
• PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery

  2023cites this paper
• KICO: Surgeon-Centered Collaborative Tool to Aid Peritoneal Carcinomatosis Assessment

  2023cites this paper
• Predictive factors of non-completion of cytoreductive surgery in colorectal peritoneal metastasis.

  2023cites this paper
• Clinical outcomes of curative surgical resection of peritoneal metastasis in patients with colorectal cancer: A long‐term follow‐up study

  2022cites this paper
• Advances in the management of peritoneal malignancies

  2022cites this paper
• New Frontiers in Management of Early and Advanced Rectal Cancer

  2022cites this paper
• Patterns and Timing of Recurrence following CRS and HIPEC in Colorectal Cancer Peritoneal Metastasis.

  2022cites this paper
• Peritoneal recurrence after resection for Stage I–III colorectal cancer: A population analysis

  2022cites this paper
• Hyperthermic intraperitoneal chemotherapy for management of gastrointestinal and biliary tract malignancies: a systematic review and meta-analysis of randomized trials

  2022cites this paper
• Nomogram for prediction of peritoneal metastasis risk in colorectal cancer

  2022cites this paper
• Pelvic Peritonectomy Poorly Affects Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Metastases

  2022cites this paper
• FDG-PET/MRI for the preoperative diagnosis and staging of peritoneal carcinomatosis: a prospective multireader pilot study

  2022cites this paper
• Tumor Load Matters – the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian Cancer

  2022cites this paper
• Second-look Surgery Detects Low Volume Recurrent Disease Following Cytoreductive Surgery for Peritoneal Carcinomatosis

  2022cites this paper
• A CT-Based Radiomics Model for Evaluating Peritoneal Cancer Index in Peritoneal Metastasis Cases: A Preliminary Study.

  2022cites this paper
• Pleura and Peritoneum

  2022cites this paper
• Second-look Surgery for Appendiceal High Grade and Colorectal Cancers Following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

  2022cites this paper
• Pelvic Exenteration in the Setting of Peritoneal Disease

  2021cites this paper
• Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases

  2021cites this paper
• Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis

  2021cites this paper
• The Accuracy of the Surgical Peritoneal Cancer Index in Patients with Peritoneal Metastases of Colorectal Cancer

  2021cites this paper
• Heated intraperitoneal chemotherapy for colorectal cancer: game over or game on?

  2021cites this paper
• The Characteristics of 206 Long-Term Survivors with Peritoneal Metastases from Colorectal Cancer Treated with Curative Intent Surgery: A Multi-Center Cohort from PSOGI

  2021cites this paper
• ASO Author Reflections: Pathologic Response Ratio (PRR) in CRS and HIPEC for Peritoneal Metastasis from Colorectal Cancer

  2021cites this paper
• Ratio of Pathological Response to Preoperative Chemotherapy in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer Correlates with Survival

  2021cites this paper
• Clinical and Molecular Features in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Colorectal Cancer

  2021cites this paper
• What is the Current Role of Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer?

  2021cites this paper
• Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2021cites this paper
• The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.

  2021cites this paper
• Seeing the whole picture: Added value of MRI for extraperitoneal findings in CRS-HIPEC candidates.

  2021cites this paper
• Fluorescence-guided surgery in colorectal cancer; A review on clinical results and future perspectives.

  2021cites this paper
• Outcomes of Cytoreduction and Oxaliplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis From Colorectal Cancer

  2021influential citation
• Peritoneal disease: key imaging findings that help in the differential diagnosis.

  2021cites this paper
• Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

  2021cites this paper
• Differences in the distribution of peritoneal metastases in right- versus left-sided colon cancer on MRI

  2021cites this paper
• Afdrif þeirra sem gengist hafa undir æxlisminnkandi skurðaðgerð og hitaða lyfjameðferð innan lífhimnu

  2020cites this paper
• Evidence-Based Strategies for the Treatment of Peritoneal Malignancies during Health Care Resource Restriction: The COVID-19 Pandemic

  2020cites this paper
• Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study

  2020cites this paper
• DIAGNOSTICS, TREATMENT AND PROGNOSIS IN PATIENTS WITH COLORECTAL CANCER AND PERITONEAL CARCINOMATOSIS (review)

  2020cites this paper
• High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy

  2020cites this paper
• Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient

  2020cites this paper
• The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan

  2020cites this paper
• Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology.

  2020cites this paper
• Traitement prophylactique des métastases péritonéales colorectales

  2020cites this paper
• Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI).

  2020cites this paper
• Métastases péritonéales de cancer colorectal Cas particuliers : découverte peropératoire, métastases péritonéales et autres sites métastatiques, récidive après chirurgie de cytoréduction

  2020cites this paper
• Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

  2020cites this paper
• Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.

  2020cites this paper
• Surgical management of recurrent colon cancer.

  2020cites this paper
• The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer

  2020cites this paper
• ASO Author Reflections: Use of Peritoneal Cancer Index (PCI) to Evaluate Carcinomatosis in Ovarian Cancer

  2020cites this paper
• Adding diagnostic laparoscopy to computed tomography for the evaluation of peritoneal metastases in patients with colorectal cancer: A retrospective cohort study.

  2020cites this paper
• Intraoperative Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients with Locally Advanced Colon Cancer: A Prospective Parallel Phase II Study.

  2020cites this paper
• Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta‐analysis

  2020cites this paper
• Adding diagnostic laparoscopy to computed tomography for the evaluation of peritoneal metastases in patients with colorectal cancer

  2020cites this paper
• Hypothermic Intraperitoneal Chemotherapy for Gastrointestinal Malignancies—A Relic of the Past or Useful Tool for Today?

  2019cites this paper
• 30 Peritonealkarzinose

  2019cites this paper
• Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of the randomized controlled trials

  2019cites this paper
• [Prevention of carcinomatosis in colon cancer].

  2019cites this paper
• Psycho-oncological distress in patients with peritoneal surface malignancies treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

  2019cites this paper
• Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery

  2019cites this paper
• Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases

  2019cites this paper
• Colorectal peritoneal metastases: Optimal management review

  2019cites this paper
• University of Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy

  2019cites this paper
• Peritoneal Carcinomatosis and Other Emergencies Not Related to Primary Colorectal Cancer

  2019cites this paper